5380029
Human VEGFR2/KDR/Flk-1 Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 19 publications
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
VEGFR2/KDR/Flk-1
Dilution
Flow Cytometry 0.25 ug/10^6 cells, Neutralization 10-50 ng/mL, CyTOF-ready
Classification
Monoclonal
Host Species
Mouse
Target Species
Human
Gene Accession No.
P35968
Gene ID (Entrez)
3791
Immunogen
S. frugiperdainsect ovarian cell lineSf21-derived recombinant human VEGFR2/KDR/Flk-1, Ala20-Glu764, Accession # P35968
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity
Detects human VEGFR2/KDR/Flk-1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) VEGFR1, rhVEGFR3 or recombinant mouse VEGFR2 is observed.
Clone
89106
Applications
Flow Cytometry, Neutralization, CyTOF
Conjugate
Unconjugated
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2
Gene Symbols
KDR
Isotype
IgG1
Purification Method
Protein A or G purified from hybridoma culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Description
- VEGFR2/KDR/Flk-1 Monoclonal specifically detects VEGFR2/KDR/Flk-1 in Human samples
- It is validated for Flow Cytometry, Neutralization, CyTOF-ready.
Compare Similar Items
Show Difference
Antigen: VEGFR2/KDR/Flk-1
Dilution: Flow Cytometry 0.25 ug/10^6 cells, Neutralization 10-50 ng/mL, CyTOF-ready
Classification: Monoclonal
Host Species: Mouse
Target Species: Human
Gene Accession No.: P35968
Gene ID (Entrez): 3791
Immunogen: S. frugiperdainsect ovarian cell lineSf21-derived recombinant human VEGFR2/KDR/Flk-1, Ala20-Glu764, Accession # P35968
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human VEGFR2/KDR/Flk-1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) VEGFR1, rhVEGFR3 or recombinant mouse VEGFR2 is observed.
Clone: 89106
Applications: Flow Cytometry, Neutralization, CyTOF
Conjugate: Unconjugated
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2
Gene Symbols: KDR
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
VEGFR2/KDR/Flk-1
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, Neutralization 10-50 ng/mL, CyTOF-ready
Classification:
Monoclonal
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P35968
Gene ID (Entrez):
3791
Immunogen:
S. frugiperdainsect ovarian cell lineSf21-derived recombinant human VEGFR2/KDR/Flk-1, Ala20-Glu764, Accession # P35968
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human VEGFR2/KDR/Flk-1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) VEGFR1, rhVEGFR3 or recombinant mouse VEGFR2 is observed.
Clone:
89106
Applications:
Flow Cytometry, Neutralization, CyTOF
Conjugate:
Unconjugated
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2
Gene Symbols:
KDR
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: VEGF-B
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 3-25 ug/mL
Classification: Monoclonal
Host Species: Mouse
Target Species: Human, Mouse
Gene Accession No.: AAB06274
Gene ID (Entrez): 7423
Immunogen: E. coli-derived recombinant human VEGF-B 167 Pro22-Arg188 Accession # AAB06274
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human and mouse VEGF-B in direct ELISAs and Western blots. Recognizes both the VEGF-B 167 and VEGF-B 186 isoforms. In Western blots, no cross-reactivity with recombinant human (rh) VEGF, rhVEGF-C, rhVEGF-D, rhCTGF, rhPlGF, rhLDGF, or rhPDGF is observed.
Clone: 58013
Applications: Western Blot, Immunohistochemistry
Conjugate: Unconjugated
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: vascular endothelial growth factor B, VEGFB, VEGF-B, VEGF-related factor, VRFVEGFL
Gene Symbols: VEGFB
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
VEGF-B
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 3-25 ug/mL
Classification:
Monoclonal
Host Species:
Mouse
Target Species:
Human, Mouse
Gene Accession No.:
AAB06274
Gene ID (Entrez):
7423
Immunogen:
E. coli-derived recombinant human VEGF-B 167 Pro22-Arg188 Accession # AAB06274
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human and mouse VEGF-B in direct ELISAs and Western blots. Recognizes both the VEGF-B 167 and VEGF-B 186 isoforms. In Western blots, no cross-reactivity with recombinant human (rh) VEGF, rhVEGF-C, rhVEGF-D, rhCTGF, rhPlGF, rhLDGF, or rhPDGF is observed.
Clone:
58013
Applications:
Western Blot, Immunohistochemistry
Conjugate:
Unconjugated
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
vascular endothelial growth factor B, VEGFB, VEGF-B, VEGF-related factor, VRFVEGFL
Gene Symbols:
VEGFB
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: VEGF-B
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 3-25 ug/mL
Classification: Monoclonal
Host Species: Mouse
Target Species: Human, Mouse
Gene Accession No.: AAB06274
Gene ID (Entrez): 7423
Immunogen: E. coli-derived recombinant human VEGF-B 167 Pro22-Arg188 Accession # AAB06274
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human and mouse VEGF-B in direct ELISAs and Western blots. Recognizes both the VEGF-B 167 and VEGF-B 186 isoforms. In Western blots, no cross-reactivity with recombinant human (rh) VEGF, rhVEGF-C, rhVEGF-D, rhCTGF, rhPlGF, rhLDGF, or rhPDGF is observed.
Clone: 58013
Applications: Western Blot, Immunohistochemistry
Conjugate: Unconjugated
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: vascular endothelial growth factor B, VEGFB, VEGF-B, VEGF-related factor, VRFVEGFL
Gene Symbols: VEGFB
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
VEGF-B
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 3-25 ug/mL
Classification:
Monoclonal
Host Species:
Mouse
Target Species:
Human, Mouse
Gene Accession No.:
AAB06274
Gene ID (Entrez):
7423
Immunogen:
E. coli-derived recombinant human VEGF-B 167 Pro22-Arg188 Accession # AAB06274
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human and mouse VEGF-B in direct ELISAs and Western blots. Recognizes both the VEGF-B 167 and VEGF-B 186 isoforms. In Western blots, no cross-reactivity with recombinant human (rh) VEGF, rhVEGF-C, rhVEGF-D, rhCTGF, rhPlGF, rhLDGF, or rhPDGF is observed.
Clone:
58013
Applications:
Western Blot, Immunohistochemistry
Conjugate:
Unconjugated
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
vascular endothelial growth factor B, VEGFB, VEGF-B, VEGF-related factor, VRFVEGFL
Gene Symbols:
VEGFB
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: VEGF-C
Dilution: Western Blot 1 ug/mL, ELISA
Classification: Monoclonal
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q6FH59
Gene ID (Entrez): 7424
Immunogen: Mouse myeloma cell line NS0-derived recombinant human VEGF-C Thr103-Arg227 (Cys156Ser) Accession # Q6FH59
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human VEGF-C in direct ELISAs and Western blots. In direct ELISAs, this antibody does not cross-react with recombinant human (rh) PDGF-AA, rhPDGF-BB, rhPlGF, rhVEGF 165 rhVEGF 206 rhVEGF-B 186 or rhVEGF-D.
Clone: 193208
Applications: Western Blot, ELISA
Conjugate: Unconjugated
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGFC, VEGF-C, VRPFLT4 ligand DHM
Gene Symbols: VEGFC
Isotype: IgG2b
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
VEGF-C
Dilution:
Western Blot 1 ug/mL, ELISA
Classification:
Monoclonal
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q6FH59
Gene ID (Entrez):
7424
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human VEGF-C Thr103-Arg227 (Cys156Ser) Accession # Q6FH59
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human VEGF-C in direct ELISAs and Western blots. In direct ELISAs, this antibody does not cross-react with recombinant human (rh) PDGF-AA, rhPDGF-BB, rhPlGF, rhVEGF 165 rhVEGF 206 rhVEGF-B 186 or rhVEGF-D.
Clone:
193208
Applications:
Western Blot, ELISA
Conjugate:
Unconjugated
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGFC, VEGF-C, VRPFLT4 ligand DHM
Gene Symbols:
VEGFC
Isotype:
IgG2b
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.